Finance Watch: $1.32bn In New Biopharma VC Financings As Year-End Approaches
Year-End Flurry Of Deals In Full Swing
Private Company Edition: In recent weeks, 19 companies disclosed venture capital funding of $20m or more, including FogPharma with a $178m series D round and Apogee’s $169m launch. Also, Avalon BioVentures spun out of Avalon Ventures with a $135m fund.
